In Serbian biopsies, the frequency was 28.6%, and in other non-endemic regions for NPC such as Europe, North America, and North Africa, the frequency of LMP1 deletion was determined to be 55–75% in the biopsies, without differences between isolates from NPC and healthy patients [40]. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.